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Summary
Human action is strongly influenced by expectations of plea-
sure. Making decisions, ranging fromwhich products to buy
to which job offer to accept, requires an estimation of how
good (or bad) the likely outcomes will make us feel [1]. Yet,
little is known about the biological basis of subjective esti-
mations of future hedonic reactions. Here, we show that
administration of a drug that enhances dopaminergic func-
tion (dihydroxy-L-phenylalanine; L-DOPA) during the imagi-
native construction of positive future life events subse-
quently enhances estimates of the hedonic pleasure to be
derived from these same events. These findings provide
the first direct evidence for the role of dopamine in themodu-
lation of subjective hedonic expectations in humans.Results and Discussion
An unresolved question is whether neuromodulatory systems
implicated in value-based decision making, in particular dopa-
mine (DA), impact on the generation of subjective estimations
of future hedonic reactions. Dopamine is a key neuromodula-
tor in reward learning and reward-seeking behavior in non-
human animals [2–4]. In humans, drugs enhancing dopami-
nergic function (e.g., dihydroxy-L-phenylalanine; L-DOPA)
have been shown to augment a striatal signal that expresses
reward prediction errors during instrumental learning, thereby
increasing the likelihood of choosing stimuli associated with
greater monetary gains [5]. When it comes to making more
complex, real-life choices, humans are endowed with an ability
to mentally simulate possible future scenarios that helps us
predict the likely emotional outcome of these events [6]. We
have recently shown that during imagination of future events,
activity in the heavily dopaminergic innervated striatum tracks
subjects’ estimates of the expected pleasure to be derived
from those events [7]. Given this set of findings, we reasoned
that if dopamine modulates reward prediction, then its
enhancement during imagination of future events should
impact on subjective estimations of future pleasure to be
derived from those events.
To test this, we measured people’s estimated pleasure of
future events both before and after imagining those events
under the influence of L-DOPA. In addition, we introduced*Correspondence: t.sharot@fil.ion.ucl.ac.uk
4These authors contributed equally to this worka decision-making task to examine how this process interacts
with choice. We presented 61 healthy volunteers with 80
different vacation destinations (e.g., Greece, Thailand) and
asked them to rate their expectations of happiness if they
were to vacation at each of these locations (phase 1, rating 1;
see Figure 1A). We then administered placebo 1 and asked
the participants 40 min later to complete a subjective state
questionnaire (e.g., level of alertness, calm, interest). Next,
we re-presented half of the destinations and instructed partic-
ipants to imagine themselves spending next year’s vacation
at those locations (Phase 2A, imagination under placebo 1).
We then administered L-DOPA (100 mg) to 29 participants
(‘‘experimental group,’’ randomly assigned) and a second
placebo pill to 32 participants (‘‘order control group’’ control-
ling for possible order confound, because L-DOPA had to be
administered after placebo in the experimental group because
of its half-life, which results in it requiring upwards of 5 hr for
elimination). Forty minutes later, all participants completed
the subjective state questionnaire again. The other half of the
stimulus set was then presented with the same instruction as
per phase 2A (phase 2B, imagination under L-DOPA or placebo
2). Participants then left the laboratory and returned 24 hr later.
On day 2 (by which time L-DOPA had been fully metabolized
and eliminated), participants were presented with 40 pairs of
destinations to which they had given equal ratings in phase
1. On each trial, they had to choose which of the two destina-
tions they would rather vacation at (phase 3, choice). Note
again that both destinations had been imagined the previous
day, one under placebo 1 and the other under L-DOPA (or
placebo 2 for the control group). Finally, all stimuli were rated
again (phase 4, final rating).
To test whether administration of L-DOPA changed subjec-
tive estimations of future pleasure, we calculated for each stim-
ulus the difference in mean-corrected hedonic ratings from
pre- (phase 1) to post- (phase 4) pharmacological manipulation
(see note at bottom of Table S1 available online for more infor-
mation). Note that an analysis of raw scores (Supplemental
Results) revealed the same findings as the analysis of mean-
corrected scores reported below. A repeated-measures
analysis of variance (ANOVA) (group [experiment/order con-
trol] 3 condition [placebo 1/L-DOPA or placebo 2] 3 choice
[selected/rejected]) revealed an interaction between group
and condition (p < 0.05). This interaction was due to an increase
in ratings for stimuli imagined under L-DOPA compared to
placebo 1 in the experiment group (p < 0.025; Figure 1B), with
no difference for stimuli imagined under placebo 1 and placebo
2 in the control group (p > 0.8; Figure 1B). This result suggests
that enhanced dopaminergic function during imagination
subsequently increases estimations of future hedonic reaction
(see Supplemental Results for additional ANOVA results).
Importantly, dopamine did not increase feelings of happiness
(see Table S1) but instead enhanced a prediction of pleasure
associated with a future event.
There was a significant correlation between the overall
increase in ratings for stimuli imagined under L-DOPA relative
to placebo 1 and the probability of choosing stimuli imagined
under L-DOPA (r = 0.5, p < 0.005). No parallel correlation was
found in the order control group (p > 0.7). Furthermore,
Figure 1. Experimental Task and Results
(A) On day 1, participants rated stimuli before pharmacological manipulation (phase 1). They then completed an imagination task under placebo 1 (phase 2A)
or L-DOPA (phase 2B; placebo 2 for order control group). On day 2, participants returned to the laboratory and completed a decision-making task (phase 3)
and a final rating task (phase 4). For full details, see Supplemental Experimental Procedures.
(B) Change in mean-corrected ratings from phase 1 to phase 4. Ratings of estimated happiness increased only for stimuli previously imagined under
L-DOPA.
(C) Difference scores (placebo 12 L-DOPA; placebo 12 placebo 2) for the change in mean-corrected ratings from phase 1 to phase 4. Ratings of estimated
happiness increased from phase 1 to phase 4 for stimuli imagined under L-DOPA relative to placebo 1 only for selected stimuli. As expected, there was no
difference in rating change for stimuli imagined under placebo 1 relative to placebo 2 in the control group for either selected stimuli or rejected stimuli.
Error bars in (B) and (C) represent standard error of the mean. *p < 0.05.
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enhanced by L-DOPA relative to placebo were also more likely
to choose stimuli imagined under L-DOPA than stimuli imag-
ined under placebo (p < 0.0001).
To further examine the relationship between rating change,
choice, and pharmacological manipulation, we focused sepa-
rately on the scores of selected stimuli and rejected stimuli.
A two-way mixed ANOVA on scores of selected stimuli
(group 3 condition) confirmed a significant interaction (p <
0.05). This interaction was driven by an increase in expected
hedonic outcome for selected stimuli previously imagined
under L-DOPA relative to placebo 1 in the experimental group
(p < 0.005; effect seen in 79% of the participants), with no differ-
ence for selected stimuli imagined under placebo 1 versus
placebo 2 in the control group (p > 0.9; see Figure 1C).
For rejected stimuli, there was no group3condition interaction
(Figure 1C). These results suggest that when estimatedhedonic outcomes were enhanced by L-DOPA, those stimuli
were more likely to be selected.
Previous studies have implicated the dopamine-innervated
striatum in signaling expectations of pleasure during imagina-
tion of future life events [7]. The current findings provide the
first evidence indicating a regulatory role for dopamine in
generating such subjective hedonic expectations in humans.
Note that these results should not be taken to imply that dopa-
mine enhances the hedonic impact of reward per se. Instead,
the findings indicate that dopamine modulates processes
related to predictions of likely future pleasure in a manner
reminiscent of its role in reward learning.
Imagination can be construed as conforming to a learning
process that enables people to estimate the emotional
reaction associated with a novel event [6, 7]. One possibility
is that by affecting learning mechanisms, L-DOPA may
strengthen this process, by affecting the association between
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generated during imagination of the pleasurable event and/
or by directly affecting the signal that mediates predictive
information during an act of imagination. This latter possibility
complements previous findings including data showing that
a signal in the striatum tracks expected pleasure during
imagination [7], as well as a growing body of literature suggest-
ing a role for dopamine in reward learning [2–5, 8–11]. It has
also been suggested that dopamine enhances incentive
salience [12, 13], where according to this view the administra-
tion of L-DOPA might be construed as enhancing the incentive
salience attributed to imagined stimuli. The current study can-
not distinguish between these two possibilities. An enhance-
ment of dopaminergic function could in principle directly
modulate incentive salience or alternatively enhance the pre-
dicted hedonic utility associated with the vacation destina-
tions, which in turn could boost incentive salience.
An alternative interpretation is that enhancing dopaminergic
function during imagination increases the experience of plea-
sure during simulation of a future event by directly altering its
hedonic impact. The ensuing hedonic reaction during this
simulation could act as a proxy for future hedonic reactions,
enhancing the predicted pleasure associated with the event.
This explanation is problematic for a number of reasons. First,
the notion that dopamine acts as a pleasure neurotransmitter
has been discounted by a large body of recent evidence (see
[12, 13] for review). Second, in the present study, we did not
observe an influence of dopamine on any measure of hedonic
reaction recorded during the pharmacological manipulation
stage (see results for phases 2A and 2B and Table S1).
However, it is possible that the effects of dopamine on valua-
tion are not limited to future events and that enhanced dopami-
nergic function during imagination modulates the present value
of a stimulus, an idea best tested with stimuli that can be
directly experienced or consumed. A final possible mechanism
is that the effects we observed reflect an L-DOPA strength-
ening, via hippocampus-dependent loops, of a memory trace
of pleasant associations made during the imagination stage.
Understanding how hedonic expectations are formed is crit-
ical both for understanding human action, which is largely
driven by estimations of future pleasure and pain [1, 6, 7],
and for understanding how pleasure expectation can go
awry in a multitude of neuropsychiatric disorders that impli-
cate dopamine, such as drug addiction [14–17]. The current
study highlights the neurobiological basis of this key aspect
of human behavior, providing direct evidence of a critical
role for dopamine in modulating the subjective pleasure
expected to be derived from future life events.
Experimental Procedures
Participants
Participants were recruited through posted advertisements and assigned
randomly to either the experimental group (16 males, 13 females, age range
21–31)or theordercontrolgroup (15males,17 females, age range20–34), blind
to condition. Participants completed a screening form for significant medical
conditions, gave informed consent, and were paid for their participation.
Experimental Design and Task
Day One
Phase 1, Rating 1. Phase 1 consisted of 80 trials. On each trial, a name of
a vacation destination appeared on screen for 2 s. The participants rated
how happy they estimated they would be if they were to vacation at that
location (from 1 = unhappy to 6 = extremely happy) by using the computer
keypad. A fixation cross was then presented for 3 s. Before the beginning
of this phase, participants completed four practice trials.Pair Construction. Stimuli were paired via a MATLAB program as imple-
mented previously [7]. Approximately 80% of trials included two options
that were rated the same in phase 1, and only data from stimuli derived
from these pairs were subsequently used in data analysis. The remaining
pairs (approximately 20%) included two options rated differently in phase 1.
Each stimulus appeared in only one pair. One member of a pair was always
presented in phase 2A and the other in phase 2B, an assignment that was
determined randomly.
Phase 2A, Imagination under Placebo 1 (Vitamin C Supplement). Phase
2A consisted of 40 trials. On each trial, a name of a vacation destination ap-
peared for 6 s. The participants imagined themselves vacationing at that
location next year and then rated how happy they would be (from 1 =
unhappy to 6 = extremely happy) and rated how vivid the image was in their
mind (from 1 = low to 6 = high). A fixation cross was then presented for 3 s.
Phase 2B, Imagination under L-DOPA (100 mg) or Placebo 2 (Vitamin C
Supplement; Different Color and Size from Placebo 1). Procedure was as
in phase 2A.
Ratings for Phase 2A and Phase 2B. Reaction times decreased in phase
2B compared to phase 2A in both groups (see Supplemental Results),
most likely as a result of practice. Absolute ratings of estimated pleasure
and vividness did not differ between phase 2B and phase 2A in either group
for either subsequently selected stimuli or rejected stimuli. Note that during
these imagination sessions, L-DOPA stimuli and placebo stimuli were imag-
ined and rated in separate sessions (phase 2A and phase 2B, respectively).
Because participants may have used an absolute evaluation scale differ-
ently on phase 2A and phase 2B (i.e., the most pleasurable stimuli would
be rated 6 in both conditions even if the most pleasurable stimuli under
L-DOPA were more pleasurable than under placebo), we cannot reliably
compare these ratings. In contrast, during phase 1 and phase 4, all stimuli
were rated intermixed at the same time. Thus, those ratings, reported in
the main text, can be reliably compared for the different types of stimuli.
Day Two
Phase 3, Choice. On each trial, two names of vacation destinations (see
‘‘Pair Construction’’ above) appeared on screen side by side for 4 s. The
word ‘‘choose’’ then appeared above the two options for an additional
2 s, and participants indicated which location they would prefer to vacation
at next year by pressing one of two buttons on the keypad. After the partic-
ipants made a response, a star appeared next to the chosen location.
Finally, a fixation cross was presented for 3 s. Choices were hypothetical.
Phase 4, Rating 2. Procedure was as in phase 1.
Additional Rating Questionnaires. Following phase 4, participants were
asked to rate all stimuli on four scales (see [7]): previous visits, familiarity,
vividness, and arousal. Three participants in each group failed to fill in these
questionnaires. No group3 condition interaction was found for any of these
scores for either selected stimuli or rejected stimuli.Supplemental Data
Supplemental Data include two tables, Supplemental Results, and
Supplemental Experimental Procedures and can be found with this article
online at http://www.cell.com/current-biology/supplemental/S0960-9822
(09)01844-2.
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